Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
2014 · Nature Medicine · 425 citations
https://doi.org/10.1038/nm.3512
S
Samuel M. Cadena
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
1.8K
Citations
14
h-index
16
i10-index
Samuel M. Cadena is an academic researcher from Acceleron Pharma (United States). The author has contributed to research in topics: Muscle Physiology and Disorders & Muscle metabolism and nutrition & Spaceflight effects on biology. The author has an h-index of 14, co-authored 33 publications.
Papers by this author
worksSupraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15
2018 · Cell Reports · 86 citations
https://doi.org/10.1016/j.celrep.2018.01.044
Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space
2019 · Scientific Reports · 56 citations
https://doi.org/10.1038/s41598-019-45821-9
ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus)
2026 · PLoS ONE · 0 citations
https://doi.org/10.1371/journal.pone.0342666
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat